Showing results (961-970 of 1,078) with videos related to
Sort By:
Pageof 108
The Journal of Pediatrics|July 20, 2015
Early Detection of Necrotizing Enterocolitis by Fecal Volatile Organic Compounds AnalysisTim G J de Meij, Marc P C van der Schee, Daan J C Berkhout, et al.Inflammatory Bowel Diseases|August 3, 2016
The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver DiseaseDirk P van Asseldonk, Bindia Jharap, Joanne Verheij, et al.JAMA|November 15, 2012
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomesGregory P Levin, Cassianne Robinson-Cohen, Ian H de Boer, et al.Journal of Crohn'S & Colitis|November 5, 2020
Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease PhenotypesM D Voskuil, L M Spekhorst, K W J van der Sloot, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2019
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) StudyJoshua D Bundy, Xuan Cai, Julia J Scialla, et al.Journal of the American Society of Nephrology : JASN|February 5, 2017
Growth Differentiation Factor-15 and Risk of CKD ProgressionViji Nair, Cassianne Robinson-Cohen, Michelle R Smith, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 30, 2019
Serum Calcification Propensity and Clinical Events in CKDJoshua D Bundy, Xuan Cai, Rupal C Mehta, et al.Alimentary Pharmacology & Therapeutics|September 9, 2020
Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort studyVera E R Asscher, Vince B C Biemans, Marieke J Pierik, et al.Diabetes Research and Clinical Practice|October 20, 2022
Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - A post-hoc analysis of the PERL studyViktor Rotbain Curovic, Neil Roy, Tine W Hansen, et al.Plos One|October 24, 2022
Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injuryMichael Andrews, Teruhiko Yoshida, Clark M Henderson, et al.Pageof 108